L-Lysine,N6-[6-[[5-[(3aS,4S,6aR)-hexahydro- 2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1- oxopentyl]amino]-1-oxohexyl]- (136910-27-5)
Identification |
Properties |
Safety Data |
|
 |
Other Product
- L-Lysine,N2,N2-bis(carboxymethyl)-N6-[6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-1-oxohexyl]-,potassium salt (1:3)
- L-Lysine,N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-,hydrazide
- L-Lysine,N2-[(1,1-dimethylethoxy)carbonyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
- Angiotensin II,N-[6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-1-oxohexyl]-5-L-isoleucine-(9CI)
- D-Lysine,N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
- Methanesulfonothioicacid,S-[2-[[6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-1-oxohexyl]amino]ethyl]ester
- L-Lysine,N2-[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
- w-Conotoxin G VIA,2-[N6-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
- D-myo-Inositol,3,4-bis(dihydrogen phosphate)1-[(2R)-3-[[6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-1-oxohexyl]oxy]-2-[(1-oxohexyl)oxy]propylhydrogen phosphate] (9CI)
- L-Lysine,N2-[4-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxobutyl]-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
- L-Isoleucine,N-[6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-1-oxohexyl]-O-phosphono-L-tyrosyl-L-a-glutamyl-L-a-glutamyl- (9CI)
- Hexanoic acid,6-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-
- L-Lysine,1,1'-[[(carboxymethyl)imino]di-2,1-ethanediyl]bis[N-(carboxymethyl)glycyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-(9CI)
- L-Lysinamide,N-[[(2S,3S)-3-(ethoxycarbonyl)-2-oxiranyl]carbonyl]-L-leucyl-L-tyrosyl-6-aminohexanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-
- L-Proline,1-[N2-(1-carboxy-3-phenylpropyl)-N6-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-L-lysyl]-,[3aS-[3aa,4b(R*),6aa]]- (9CI)
- L-Proline,1-[N2-(1-carboxy-3-phenylpropyl)-N6-[N-[N-[6-[[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]-1-oxohexyl]-b-alanyl]-b-alanyl]-L-lysyl]-, [3aS-[3aa,4b(R*),6aa]]- (9CI)
- Vasopressin,1-(3-mercaptopropanoicacid)-8-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
- Substance P,3-[N6-[5-(hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]-L-lysine]-,[3aS-(3aa,4b,6aa)]- (9CI)
- Benzoic acid,4-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-
- Benzoic acid,4-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]-